|
ZC3HAV1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.61069999998964E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.298160E-03 |
| Normal-vs-Stage2 |
5.845100E-04 |
| Normal-vs-Stage3 |
1.10799999952782E-07 |
| Normal-vs-Stage4 |
1.93429999995054E-06 |
| Stage1-vs-Stage2 |
1.364770E-01 |
| Stage1-vs-Stage3 |
7.602200E-03 |
| Stage1-vs-Stage4 |
3.676000E-02 |
| Stage2-vs-Stage3 |
8.147800E-01 |
| Stage2-vs-Stage4 |
8.567600E-01 |
| Stage3-vs-Stage4 |
9.522600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29219999999808E-05 |
| Normal-vs-AfricanAmerican |
2.56950000054879E-07 |
| Normal-vs-Asian |
3.089600E-01 |
| Caucasian-vs-AfricanAmerican |
2.916300E-02 |
| Caucasian-vs-Asian |
5.864800E-01 |
| AfricanAmerican-vs-Asian |
1.346430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65789999998045E-06 |
| Normal-vs-Female |
1.833050E-04 |
| Male-vs-Female |
2.840800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.783500E-03 |
| Normal-vs-Age(41-60Yrs) |
8.41129999999968E-05 |
| Normal-vs-Age(61-80Yrs) |
1.53625000000046E-05 |
| Normal-vs-Age(81-100Yrs) |
2.840500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.154400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.346800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.650200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.755400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.253800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.150200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.681800E-02 |
| Normal-vs-Grade 2 |
3.682400E-03 |
| Normal-vs-Grade 3 |
9.09959999573218E-08 |
| Normal-vs-Grade 4 |
3.87840000000139E-05 |
| Grade 1-vs-Grade 2 |
7.511000E-01 |
| Grade 1-vs-Grade 3 |
4.508000E-01 |
| Grade 1-vs-Grade 4 |
5.481200E-01 |
| Grade 2-vs-Grade 3 |
3.239000E-03 |
| Grade 2-vs-Grade 4 |
6.425600E-02 |
| Grade 3-vs-Grade 4 |
8.033400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.032350E-02 |
| Normal-vs-ccB subtype |
4.96029999996761E-06 |
| ccA subtype-vs-ccB subtype |
8.324800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.31729999983821E-07 |
| Normal-vs-N1 |
2.916200E-01 |
| N0-vs-N1 |
5.144200E-01 |
|
|
